BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2025.
World J Cardiol. Dec 26, 2025; 17(12): 112046
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.112046
Figure 3
Figure 3 Apixaban levels and clotting time-post evaluation across the four drug dosage groups. A: Distribution of apixaban plasma concentrations across prescribed dose groups, displayed as box-and-whisker plots. Boxes represent the interquartile range with the median shown as a horizontal line; whiskers indicate values within 1.5 × interquartile range, and points beyond are outliers; B: Post-drug clotting time (clotting time-post) values across apixaban dose groups, presented as box-and-whisker plots. Boxes represent the interquartile range with the median shown as a horizontal line, whiskers indicate values within 1.5 × interquartile range, and points beyond are outliers; C: Post-treatment clotting time (clotting time-post) mean values across apixaban dose groups, further stratified by the presence or absence of bleeding events. CT: Clotting time.


Write to the Help Desk